Abstract
Forty-three patients with inoperable and/or recurring malignant gliomas were treated with a combination of Adriamycine ( 45 mg/m 2 ) and 4-dimethyl-epipodophyllotoxin d -thenylidene (VM 26) ( 60 mg/m 2 for two days). These cycles of treatment were repeated as soon as the hematological restoration was complete. The treatment was well tolerated and the clinical condition of 31 out of 43 glioblastoma patients improved during the two months after the beginning of the treatment. Examination of the results obtained reveals the following characteristics: 1. 1. A low degree of efficiency of this combination in the treatment of brain metastases, except for breast cancer metastases. 2. 2. Absence of complete correlation between the clinical results observed and the cinegammagraphic developments. 3. 3. Similarity of the results independent of the initial localization. 4. 4. Establishment of a six-months median survival period, with ten patients at present in a state of apparently complete remission, 180–506 days after beginning of the treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
